• In the past quarter, Align Technology reported revenue and earnings per share that exceeded analyst expectations, while continuing to advance its Invisalign clear aligners and iTero intraoral scanners.
• The combination of outperformance against forecasts and ongoing innovation in digital orthodontics is sharpening investor focus on Align’s long-term business drivers.
• With Align’s recent earnings beat highlighting its innovation in clear aligners and dental scanning, we’ll now assess how this shapes the investment narrative.

Rare earth metals are the new gold rush. Find out which 27 stocks are leading the charge.

Align Technology Investment Narrative Recap

To own Align Technology, you need to believe that demand for clear aligners and digital orthodontics can overcome recent macro and competitive pressures. The latest quarter’s modest revenue beat and ongoing innovation do not materially change the near term tension between softer case starts and Align’s push into higher value scanners and advanced treatment solutions, so the key catalyst remains execution on new products, while the biggest risk is continued pressure on aligner volumes and pricing.

The Q1 2026 earnings release, which paired a small revenue and EPS beat with guidance for low single digit full year growth and improving margins, is central here. It ties directly to the catalyst of Align’s new Invisalign and iTero innovations, where management is aiming for better case acceptance and higher margin hardware sales even as the company experiences mix shifts toward lower priced products and more cost conscious geographies.

Yet investors should also be aware that pricing pressure and a shift to lower priced products could...

Align Technology's narrative projects $4.7 billion revenue and $726.5 million earnings by 2029.

Uncover how Align Technology's forecasts yield a $201.69 fair value, a 13% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts saw Align reaching about US$5.0 billion in revenue and US$801.1 million in earnings by 2029, which is far more bullish than consensus and may look either more achievable or more stretched now that Q1 has highlighted both innovation progress and ongoing pricing and demand risks.

Explore 6 other fair value estimates on Align Technology - why the stock might be worth 13% less than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Align Technology research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Align Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Align Technology's overall financial health at a glance.

Looking For Alternative Opportunities?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.